DDX3X and lung carcinoma: DDX3 overexpression is associated with poor survival in lung cancer, and the development and use of the DDX3 inhibitor, RK-33, showed tumor regression by inducing apoptosis of tumor cells in a xenograft model of lung cancer and was associated with an accumulation of DNA damage [23].